advertisement

---

Quaranta L 16

Showing records 1 to 16 | Display all abstracts from Quaranta L

96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Quaranta L
Journal of clinical medicine 2021; 10:

---

96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Katsanos A; Riva I
Expert Opinion on Drug Safety 2021; 0: 1-15

---

96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Bruttini C
Journal of clinical medicine 2021; 10:

---

96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Bozkurt B
Expert Opinion on Drug Safety 2021; 0: 1-15

---

96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
De Angelis G
Journal of clinical medicine 2021; 10:

---

96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Holló G
Expert Opinion on Drug Safety 2021; 0: 1-15

---

96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Montescani S
Journal of clinical medicine 2021; 10:

---

96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Quaranta L
Expert Opinion on Drug Safety 2021; 0: 1-15

---

96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Ardizzone A
Journal of clinical medicine 2021; 10:

---

96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Oddone F
Expert Opinion on Drug Safety 2021; 0: 1-15

---

96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Katsanos A; Carnevale C
Journal of clinical medicine 2021; 10:

---

96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Irkec M
Expert Opinion on Drug Safety 2021; 0: 1-15

---

96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Carnevale C
Journal of clinical medicine 2021; 10:

---

96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Dutton GN
Expert Opinion on Drug Safety 2021; 0: 1-15

---

96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Oddone F; Riva I
Journal of clinical medicine 2021; 10:

---

96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Konstas AG
Expert Opinion on Drug Safety 2021; 0: 1-15

---